Summary
Within project Z02 all PIs of the CRC will be provided with (1) shared primary myeloid malignancy samples from the Heidelberg Cell and Liquid Biobank and (2) PDX mouse models for preclinical in vivo treatment assays. We are going to set up a dedicated Mouse Leukemia Clinic for analysis and treatment of PDX models. This mouse clinic will foster collaboration, accelerate research due to standardized procedures and will allow comparisons of diseases and treatment across individual projects. At the same time, the professional team will use all possible 3R criteria to reduce, refine and replace mouse experiments.

principal Investigator
Irmela Jeremias, Prof. Dr. med.
Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital

principal Investigator
Nadine Volk, Dr. sc. hum.
Department of Hematology Oncology and Rheumatology, Heidelberg University Hospital

Team:
Core Projects











